Smad3 Mediates Diabetic Dyslipidemia and Fatty Liver in db/db Mice by Targeting PPARδ

Transforming growth factor-β (TGF-β)/Smad3 signaling has been shown to play important roles in fibrotic and inflammatory diseases. However, the role of Smad3 in dyslipidemia and non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes remains unclear, and whether targeting Smad3 has a therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Huijun, Zhong, Yu, Wang, Honglian, Tang, Patrick Ming-Kuen, Xue, Vivian Weiwen, Chen, Xiaocui, Chen, Jiaoyi, Huang, Xiaoru, Wang, Cheng, Lan, Huiyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380492/
https://www.ncbi.nlm.nih.gov/pubmed/37511155
http://dx.doi.org/10.3390/ijms241411396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380492/
https://www.ncbi.nlm.nih.gov/pubmed/37511155
http://dx.doi.org/10.3390/ijms241411396

Ejemplares similares